Workflow
Samsara (IOT) - 2026 Q3 - Earnings Call Presentation
2025-12-04 22:00
Disclaimer and Statement Regarding Use of Non-GAAP Measures This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may relate to, but are not limited to, expectations of future operating results or financial performance, market size and growth, industry developments and trends, the calculation of certain of our financial and operating metrics, capital expenditures, future p ...
Argan(AGX) - 2026 Q3 - Earnings Call Presentation
2025-12-04 22:00
Financial Highlights - Q3 2026 consolidated revenues reached $251 million, a 2% decrease year-over-year but a 6% increase sequentially compared to Q2 2026[5] - Q3 2026 earnings per diluted share increased by 9% year-over-year to $2.17[5] - Q3 2026 EBITDA was $40.3 million, representing 16% of revenue[5] - The quarterly dividend increased by 33% to $0.50 per common share[5] Backlog and Projects - The project backlog reached a record of approximately $3.0 billion as of October 31, 2025[5] - The current backlog represents approximately 6GW in new energy builds[5] - Recent additions to the backlog include a 1,350 MW combined cycle power plant and an 860 MW natural gas-fired power plant, both in Texas[5] - Natural Gas projects account for 79% of the backlog, Renewable projects 16%, and Industrial projects 5%[20] Market Drivers and Growth - Electricity demand is projected to increase by 25% by 2030 and 78% by 2050[21, 40] - Data center power demand is projected to double to 945 TWh by 2030[14] - Electricity demand from EVs is projected to reach 780 TWh in 2030, increasing from 180 TWh in 2024[16] Balance Sheet and Capital Allocation - Cash, cash equivalents, and investments totaled $727 million as of October 31, 2025[28] - Net liquidity was $377 million as of October 31, 2025[28] - $109.6 million has been returned to shareholders through share repurchases since November 2021[33]
HPE(HPE) - 2025 Q4 - Earnings Call Presentation
2025-12-04 22:00
FY25 Financial Performance - HPE's revenue reached $34.3 billion, a 14% increase year-over-year[20] - The company's full-year non-GAAP diluted net EPS was $1.94, exceeding the guidance of $1.88 to $1.92[20] - HPE generated a full-year free cash flow of $986 million, surpassing the guidance of approximately $700 million[20] - The company's Annual Recurring Revenue (ARR) reached approximately $3.2 billion, a 62% increase year-over-year, with Software and Services contributing over 80% of the ARR[20] Q4 FY25 Financial Highlights - Net revenue for Q4 FY25 was $9.7 billion, a 14% increase year-over-year and a 6% sequential increase[32] - ARR for Q4 FY25 was $3.2 billion, a 62% increase year-over-year and a 3% sequential increase[32] - Non-GAAP gross margin for Q4 FY25 was 36.4%, a 5.5 percentage point increase year-over-year and a 6.5 percentage point sequential increase[32] - Non-GAAP operating profit for Q4 FY25 was $1.2 billion, a 26% increase year-over-year and a 52% sequential increase[32] Strategic Priorities and Outlook - HPE aims to achieve approximately $1 billion in annualized structural cost savings by FY28 through Juniper synergies and Catalyst initiatives[16] - The company targets to generate more than $3.5 billion in Free Cash Flow (FCF) by FY28[16] - HPE anticipates revenue growth of 17% to 22% as reported for full year FY26, or 5% to 10% on a pro forma basis[55]
The Cooper Companies(COO) - 2025 Q4 - Earnings Call Presentation
2025-12-04 22:00
CooperCompanies | | | | FY26 Guidance | Q1 2026 Guidance | | --- | --- | --- | --- | --- | | | Total | $4,299 - | $4,338 | $1,019 - $1,030 | | | | (4.5% - | 5.5% organic growth) | (3% - 4% organic growth) | | e | | | | | | u n e | CooperVision | $2,900 - | $2,925 | $693 - $700 | | v | | (4.5% - | 5.5% organic growth) | (3.5% - 4.5% organic growth) | | e R | | | | | | | CooperSurgical | $1,399 - | $1,413 | $327 - $330 | | | | (4% - | 5% organic growth) | (2% - 3% organic growth) | | P | | | | | | A A | EPS | ...
SentinelOne(S) - 2026 Q3 - Earnings Call Presentation
2025-12-04 21:30
Financial Performance - ARR grew by 23% year-over-year, reaching $1,055 million in Q3 FY26[11] - Revenue increased by 23% year-over-year to $259 million in Q3 FY26[11] - Gross margin improved to 79% in Q3 FY26[11] - Operating margin reached 7% in Q3 FY26, a nearly 1,200 bps improvement year-over-year[11] Customer Growth and Platform Adoption - Customers with ARR of $100K+ grew by 20% year-over-year in Q3 FY26[11] - Approximately 50% of quarterly bookings came from emerging products[10, 11, 14] Acquisitions and Product Development - Observo AI acquisition enriches and filters data, cutting volume by up to 80%[10, 16] - Observo AI customers have seen a 50%+ cost savings in Infrastructure & SIEM costs[18, 22] - Observo AI customers have seen a ~40% reduction in incident resolution time on average[18, 22] Market and Technology Leadership - The company estimates a total addressable market of $100B+ in 2025[54] - Gartner's Peer Insights gave a 98% "Willingness to Recommend" Rating for Cloud-Native Application Protection Platforms (CNAPP)[64, 83] - IDC's study shows Purple AI reduces the likelihood of a major security event by 60%[69] - IDC's study shows Purple AI leads to 55% faster remediation of security threats[70]
ChargePoint(CHPT) - 2026 Q3 - Earnings Call Presentation
2025-12-04 21:30
© 2025 ChargePoint Holdings, Inc. 2 • ChargePoint has provided historical financial information in this presentation that has not been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). ChargePoint uses these non-GAAP financial measures internally in analyzing its financial results. ChargePoint believes that the use of these non-GAAP financial measures is useful to investors to evaluate ongoing operating results and trends and believes they provide meaningful ...
Pliant Therapeutics (NasdaqGS:PLRX) FY Earnings Call Presentation
2025-12-04 17:30
Developing Novel Integrin-Based Therapeutics DECEMBER 2025 © 2025 PLIANT THERAPEUTICS Disclaimers This presentation has been prepared by Pliant Therapeutics, Inc. ("we," "us," "our," "Pliant" or the "Company"). The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this presentation unless stated otherwise, and this presentation shall not under any circumstances create an implication that th ...
Methode Electronics(MEI) - 2026 Q2 - Earnings Call Presentation
2025-12-04 16:00
Financial Performance - Q2 Fiscal Year 2026 - Net sales for Fiscal 2Q'26 were $247 million[6], a 16% decrease compared to the $292.6 million in 2Q'25[18] - Adjusted EBITDA for Fiscal 2Q'26 was $18 million[6], while in 2Q'25 it was $26.7 million[19] - Free cash flow improved by $47 million in 2Q'26 compared to the prior year[6] - Net debt reduced by $29.6 million, a 12% year-over-year decrease[25] Financial Performance - 1H Fiscal Year 2026 - Net sales for Fiscal 1H'26 were $487 million[6] - Adjusted EBITDA for Fiscal 1H'26 was $33 million[6] - Free cash flow for Fiscal 1H'26 was +$6 million[6] Guidance and Outlook - Fiscal year 2026 sales guidance reaffirmed at $900 million to $1 billion[7] - Fiscal year 2026 adjusted EBITDA guidance reaffirmed at $70 million to $80 million[7] - Capital expenditures are expected to be between $24 million and $29 million for fiscal year 2026[27] Strategic Focus - Aligning product portfolio with megatrends, including data centers and vehicle electrification[9] - Power Solutions offerings net sales increased from $116 million in FY22 to $252 million in FY25[13]
Hovnanian Enterprises(HOV) - 2025 Q4 - Earnings Call Presentation
2025-12-04 16:00
Financial Performance - Total revenues for Q4 2025 were $818 million, compared to guidance of $750-$850 million[11] - Adjusted homebuilding gross margin for Q4 2025 was 163%, within the guidance of 150%-165%[11] - Income from unconsolidated joint ventures was $13 million in Q4 2025, exceeding the guidance of $8-$12 million[11] - Adjusted EBITDA for Q4 2025 was $89 million, compared to guidance of $77-$87 million[11] - Adjusted income before income taxes for Q4 2025 was $49 million, compared to $126 million in Q4 2024[15] - Adjusted homebuilding gross margin decreased from 217% in Q4 2024 to 163% in Q4 2025[15] Contracts and Traffic - Contracts, including domestic unconsolidated joint ventures, decreased from 1,571 in Q4 2024 to 1,450 in Q4 2025[19] - The company's total liquidity was $2728 million in cash and cash equivalents, $63 million in restricted cash, and $1250 million available under a senior secured revolving credit facility as of October 31, 2025[8] - Total lots controlled were 38,742 as of October 31, 2025[49] - Option deposits as of October 31, 2025, were $3332 million[84]
John Wiley & Sons(WLY) - 2026 Q2 - Earnings Call Presentation
2025-12-04 15:00
Financial Performance - Adjusted revenue decreased by 1% to $422 million, but excluding divestitures and foreign exchange impacts, the decrease was driven by an 11% decline in Learning, offset by 5% growth in Research [38, 41] - Adjusted EPS increased by 12% to $1.10, driven by a 14% increase in Adjusted Operating Income [38, 41] - Adjusted EBITDA increased by 8% to $115 million, with the Adjusted EBITDA margin up 240 basis points to 273% [38, 41] Segment Performance - Research revenue increased by 5%, with Research Publishing up 7% and Research Solutions down 5% [41, 14, 42] - Learning revenue decreased by 11%, with Academic down 8% and Professional down 16% [41, 45] AI Initiatives - Secured a $6 million LLM training licensing agreement in Q2, bringing year-to-date AI revenue to $35 million [14] - Launched the AI Gateway, a content enrichment and distribution platform, and have over 30 publisher partners for the Nexus content licensing service [8, 14, 25] Operational Efficiency and Capital Allocation - Corporate expenses reduced by 18% in Q2 [8, 14, 52] - Share repurchases increased by 69% to $21 million in Q2, with a total of $73 million returned to shareholders YTD through dividends and repurchases [8, 54] Outlook - The company is on track to deliver full year Free Cash Flow outlook of $200M [56]